MIRA INFORM REPORT

 

 

Report Date :

12.12.2013

 

IDENTIFICATION DETAILS

 

Name :

MMC HEALTHCARE LIMITED

 

 

Registered Office :

No.61, Kurinji Street, Fathima Nagar, Valasarawakkam, Chennai – 600087, Tamilnadu

 

 

Country :

India

 

 

Financials (as on) :

31.03.2013

 

 

Date of Incorporation :

28.02.1996

 

 

Com. Reg. No.:

18-034651

 

 

Capital Investment / Paid-up Capital :

Rs.13.672 Millions

 

 

CIN No.:

[Company Identification No.]

U93090TN1996PLC034651

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Manufacturer of Pharma Products.

 

 

No. of Employees :

160 (Approximately) (30 In Office) (130 In Factory)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (30)

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Maximum Credit Limit :

USD 267000

 

 

Status :

Moderate

 

 

Payment Behaviour :

Slow but correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having a moderate track record.

 

Profitability of the company appears to be low.

 

However, trade relations are fair. Business is active. Payment terms are slow but correct.

 

The company can be considered for business dealing with some caution. 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31st, 2013

 

Country Name

Previous Rating

(31.12.2012)

Current Rating

(31.03.2013)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

The current downturn provides an opportunity to push ahead with reforms to accelerate growth, says the latest India Development Update report released by the World Bank. The report says that the adverse effects of rupee depreciation are likely to be offset by the gains in the exports performance due to improved external competitiveness. Since May this year, the local currency has depreciated substantially and fell to a record level of Rs 68.85 to a dollar on August, 28.

 

A stagflation like situation appears to have arisen as inflation jumped to an eight month high of 6.46 % for the month of September. It is up from 6.10 % in August. Growth continues to be muted with factory output plunging to 0.6  % in August. Onion prices have risen nearly 300 % from last September. Vegetables cost nearly 90 % more than they did last year. Wake up to the economic contribution of slum dwellers. They contribute more than 7.5 % to the country’s gross domestic product, according to a recent study conducted in 50 top cities.

 

136000 estimated number of jobs created during the second quarter of the current financial year. 50000 estimated number of additional jobs in the field of corporate social responsibility in the coming years.

 

The International Finance Corporation expects to come out with its rupee linked bonds issue before the end of 2013 as a part of its plan to raise $ 1 billion. The Apple iPhone 5c (Rs 41900 for 16 GB variant) and 5s (Rs 53500 for 16GB variant) has been launched in India from 1st November.

 

The Land Acquisition Act to provide just and fair compensation to farmers will come into force from January 1 next year, said Rural Development Minister Jairam Ramesh. The Act replaces a 119 year old registration. The Securities and Exchange Board of India has approved the trading of currency futures on the Bombay Stock Exchange. The exchange plans to launch the currency futures platform with advanced trading technology by the end of November.

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

ICRA

Rating

BB- (Term Loan Facilities)

Rating Explanation

Have moderate risk of default.

Date

March 2013

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

INFORMATION PARTED BY

 

Name :

Mr. Shakti

Designation :

Accountant

Contact No.:

91-44-24868412

Date :

12.12.2013

 

 

LOCATIONS

 

Registered Office/ Corporate Office  :

No.61, Kurinji Street, Fathima Nagar, Valasarawakkam, Chennai – 600087, Tamilnadu, India

Tel. No.:

91-44-24868412/ 8413 / 24866348/ 6358

Mobile No.:

91-9841084304 (Jayaraman)

Fax No.:

91-44-24866378

E-Mail :

mncfactory@vsnl.net

gmaccounts@mmchealthcarindia.com

mmcsales@vsnl.net

mmchr@mmchealthcareindia.com

Website :

www.mmchealthcareindia.com

Area :

3000 Sq. ft

Location :

Owned

 

 

Factory 1 :

No. 34-B, SIDCO Industrial Estate, Thirumazisai, Chennai-602107, Tamilnadu, India

Tel. No.:

91-44-26810201

Fax No.:

91-44-26810202

Area :

36000 sq. ft.

Location :

Owned

 

 

Factory 2 :

Solan- Kalka State Highway, NH-22, Deon Ghat, Solan-173211, Himachal Pradesh, India

Tel. No.:

91-172-228401/ 228402

Fax No.:

91-172-227013

 Area :

32000 sq. ft.

Location :

Owned

 

 

DIRECTORS

 

As on: 31.03.2013

 

Name :

Mr. Ramasamy Savrirajan Jayaraman

Designation :

Whole Time Director

Address :

No. 7, Maria Station, Sathya Nagar Extension, Padi, Chennai-600050, Tamilnadu, India

Date of Birth/Age :

12.04.1956

Date of Appointment :

26.02.1996

DIN No.:

02099884

 

 

Name :

Mr. Mariapppan Ravichandran

Designation :

Whole Time Director

Address :

No. 2, Periyar Street, Gandhi Nagar West Avadi, Chennai-600054, Tamilnadu, India

Date of Birth/Age :

18.05.1955

Date of Appointment :

01.05.2003

DIN No.:

02099849

 

 

Name :

Mr. Malliab Rajarathinam

Designation :

Whole Time Director

Address :

No. 99, Metro Nagar ,Alapakkam, Chennai – 600116, Tamilnadu, India

Date of Birth/Age :

25.04.1957

Date of Appointment :

01.04.2005

DIN No.:

02100011

 

 

Name :

Mrs. Jayaraman Girjadevi

Designation :

Whole Time Director

Address :

No. 7, Maria Station, Sathya Nagar Extension, Padi, Chennai-600050, Tamilnadu, India

Date of Birth/Age :

11.06.1963

Date Of Appointment :

01.05.2003

DIN No.:

02628077

 

 

Name :

Mrs. Rajarathinam Shanti

Designation :

Director

Address :

No. 99, Metro Nagar ,Alapakkam, Chennai – 600116, Tamilnadu, India

Date of Birth/Age :

11.06.1963

Date Of Appointment :

01.04.2008

DIN No.:

02722960

 

 

Name :

Mrs. R. Vidyavathi

Designation :

Director

 

 

KEY EXECUTIVES

 

Name :

Mr. Shakti

Designation :

Accountant

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on: 31.03.2013

 

Details of Shareholders holding more than 5% shares in the company

 

 

As at 31-03-2013

Name of the Shareholder

No. of Shares Held

% of Holding

R.R. Shanthi

120644

8.83

M. Rajarathinam

100126

7.32

R. Subash Vallab

140961

10.31

M. Ravichandra

182203

13.33

Vidyavathi

106396

7.78

R. S. Jayaraman

193321

14.14

Girijia Devi

105484

7.72

W. Gideon Dhanasekaran

87128

6.37

Jothi Arulmani

79720

5.83

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Pharma Products.

 

 

Imports :

 

Products :

Finished Goods

Countries :

·         Sri Lanka

·         Algeria

 

 

Terms :

 

Selling :

Credit

 

 

Purchasing :

Credit

 

 

GENERAL INFORMATION

 

Suppliers :

·         Subham Pharma Private Limited

·         Rathna Traders

 

 

Customers :

Consignment Agents

·         Markss HLC Private Limited

 

 

No. of Employees :

160 (Approximately) (30 In Office) (130 In Factory)

 

 

Bankers :

·         State Bank of India, SME Guindy, Chennai - 600087, Tamilnadu, India

·         ICICI Bank Limited, Chennai, Tamilnadu, India

 

 

Facilities :

Cash Credit Rs.66.000 Millions (From State Bank of India)

 

(Rs. In Millions)

Secured Loan

As on

31.03.2013

As on

31.03.2012

LONG TERM BORROWINGS

 

 

Indian Rupee Term Loan from Banks

4.082

6.503

Finance lease obligation

0.346

0.288

SHORT TERM BORROWINGS

 

 

Cash Credits from Banks

54.084

49.680

 

 

 

Total

58.512

56.471

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

CRCKVN and Associates

Chartered Accountants

Address :

Chennai – 600018, Tamilnadu, India

 

 

Cost Accountants :

 

Name :

M Chitra and Associates

Cost Accountants

Address :

Chennai – 600092, Tamilnadu, India

 

 

Sister Concern :

·         Hepta Pharma Private Limited

·         MMC Healthcare (Himachal Pradesh) Private Limited

 

 

CAPITAL STRUCTURE

 

As on: 31.03.2013

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

1500000

Equity Shares

Rs.10/- each

Rs.15.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

1367244

Equity Shares

Rs.10/- each

Rs.13.672 Millions

 

 

 

 

 

b. Reconciliation of Shares Outstanding at the beginning and at the end of the reporting period

 

 

As at 31-03-2013

Particulars

Number

Rs. In Millions

Shares Outstanding at the beginning of the year

1367244

13.672

 

 

 

Shares Outstanding at the end of the year

1367244

13.672

 

 

b) Details of Shareholders holding more than 5% shares in the company

 

 

As at 31-03-2013

Name of the Shareholder

No. of Shares Held

% of Holding

R.R. Shanthi

120644

8.83

M. Rajarathinam

100126

7.32

R. Subash Vallab

140961

10.31

M. Ravichandra

182203

13.33

Vidyavathi

106396

7.78

R. S. Jayaraman

193321

14.14

Girijia Devi

105484

7.72

W. Gideon Dhanasekaran

87128

6.37

Jothi Arulmani

79720

5.83

 

 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

 

31.03.2013

31.03.2012

EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

 

13.672

13.672

(b) Reserves & Surplus

 

53.181

51.005

(c) Money received against share warrants

 

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

 

0.000

0.000

Total Shareholders’ Funds (1) + (2)

 

66.853

64.677

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

 

4.428

6.791

(b) Deferred tax liabilities (Net)

 

0.000

0.000

(c) Other long term liabilities

 

0.000

0.000

(d) long-term provisions

 

3.727

3.566

Total Non-current Liabilities (3)

 

8.155

10.357

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

 

59.659

54.130

(b) Trade payables

 

49.794

30.924

(c) Other current liabilities

 

6.834

15.629

(d) Short-term provisions

 

9.969

5.409

Total Current Liabilities (4)

 

126.256

106.092

 

 

 

 

TOTAL

 

201.264

181.126

 

 

 

 

ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

 

61.369

61.638

(ii) Intangible Assets

 

8.873

10.138

(iii) Capital work-in-progress

 

0.000

0.875

(iv) Intangible assets under development

 

0.000

0.000

(b) Non-current Investments

 

0.000

0.000

(c) Deferred tax assets (net)

 

0.000

0.000

(d)  Long-term Loan and Advances

 

1.303

1.272

(e) Other Non-current assets

 

0.000

0.000

Total Non-Current Assets

 

71.545

73.923

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

 

0.000

0.000

(b) Inventories

 

65.807

50.376

(c) Trade receivables

 

55.491

46.454

(d) Cash and cash equivalents

 

0.467

1.313

(e) Short-term loans and advances

 

7.954

9.060

(f) Other current assets

 

0.000

0.000

Total Current Assets

 

129.719

107.203

 

 

 

 

TOTAL

 

201.264

181.126


 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2013

31.03.2012

 

SALES

 

 

 

 

 

Income

 

412.281

384.064

 

 

Other Income

 

0.060

0.679

 

 

TOTAL                                     (A)

 

412.341

384.743

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of Materials Consumed

 

120.731

140.565

 

 

Purchases of Stock in trade

 

136.492

95.146

 

 

Changes in Inventories of Finished goods, Work-in-progress and Stock-in-trade

 

(13.960)

(1.061)

 

 

Employee benefits Expenses

 

63.313

48.737

 

 

Other Expenses

 

86.612

81.607

 

 

Exceptional Items – Income tax demand Ass yr 2012-13

 

0.052

0.137

 

 

Extra ordinary items – Prior period item

 

0.060

0.000

 

 

TOTAL                                     (B)

 

393.300

365.131

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

 

19.041

19.612

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

 

10.045

9.031

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

 

8.996

10.581

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

 

4.694

3.394

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                               (G)

 

4.302

7.187

 

 

 

 

 

Less

TAX                                                                  (H)

 

1.329

2.221

 

 

 

 

 

 

PROFIT AFTER TAX (G-H)                                (I)

 

2.973

4.966

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

15.319

12.086

 

 

 

 

 

 

Earnings Per Share (Rs.)

 

2.17

3.63

 

 

Expected Sales (2013-2014): Rs.500.000 Millions

 

The above information has been parted by Mr. Shakti

 

 

KEY RATIOS

 

PARTICULARS

 

 

 

31.03.2013

31.03.2012

PAT / Total Income

(%)

 

0.72

1.29

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

 

1.04

1.87

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

 

2.14

3.99

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

 

0.06

0.11

 

 

 

 

 

Debt Equity Ratio

(Total Debt/Networth)

 

 

0.96

0.94

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

 

1.03

1.01

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

Yes

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

Yes

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last two years

Yes

12]

Profitability for last two years

Yes

13]

Reasons for variation <> 20%

--

14]

Estimation for coming financial year

Yes

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

Yes

18]

Major customers

Yes

19]

Payments terms

Yes

20]

Export / Import details (if applicable)

Yes

21]

Market information

--

22]

Litigations that the firm / promoter involved in

--

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

--

26]

Buyer visit details

--

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

Yes

 

 

UNSECURED LOAN

(Rs. In Millions)

Particular

As on

31.03.2013

As on

31.03.2012

SHORT TERM BORROWINGS

 

 

Deposit

4.350

4.450

Others (pl specify) Loans from Directors

1.225

0.000

Total

5.575

4.450

 

 

MACRO ECONOMIC OVERVIEW:

 

As per the Pharma Trac Market Intelligence report 2013, the domestic Indian pharmaceutical market has grown at a pace of about 14% in the year 2012 (Jan to Dec 2012). The IMS report estimates that the growth of Rs.720000.000 Millions Indian Pharmaceutical market will be in the range of 14% - 17% during 2012 -2016. The industry growth estimates may undergo a downward revision triggered by the recent slowing down of the Indian economy that is estimated to clock about 5% of GDP growth in 2013 against the peak growth rate of about 9% during 2005 to 2010. But, we believe that the growth rate will hover around 13- 14% as the industry is moderately insulated from economic growth cycles.

 

 

TRADE REFERENCE

 

·         Subham Pharma Private Limited

·         Rathna Traders

·         Markss HLC Private Limited

 

FIXED ASSETS

 

Tangible Assets

·         Land

·         Buildings

·         Plant and Equipments

·         Furniture and Fixtures

·         Vehicles

·         Office Equipments

 

Intangible Assets

·         Computers and Computer Software

·         Technical Know how

·         Copyrights

·         Patents

·         Trade Marks


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.61.33

UK Pound

1

Rs.100.79

Euro

1

Rs.84.38

 

 

INFORMATION DETAILS

 

Information Gathered by :

HTL

 

 

Report Prepared by :

VRN

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

4

PAID-UP CAPITAL

1~10

3

OPERATING SCALE

1~10

4

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

4

--PROFITABILIRY

1~10

3

--LIQUIDITY

1~10

3

--LEVERAGE

1~10

3

--RESERVES

1~10

3

--CREDIT LINES

1~10

3

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

 

 

 

TOTAL

 

30

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.